一个提桑尼丁戒断的案例和恢复的道路
Tomas Escobar Gil1, Kevin J McGeorge1, Aaron J Jones1
1Internal Medicine, University of New Mexico School of Medicine, Albuquerque, USA.
Cureus
|March 4, 2024
概括
本案例报告详细介绍了慢性疼痛患者的提桑尼丁戒断管理方法. 一种独特的巴比特剂量成功地解决了戒断症状,使得人们可以转向甲基醇来改善疼痛管理.
科学领域:
- 药理学 药理学是指药理学的学科.
- 神经学 神经学
- 疼痛管理 疼痛管理
背景情况:
- 提扎尼丁是一种来自伊米达的肌肉松剂,经常用于慢性疼痛.
- 缺少提桑尼丁戒断的标准化方案,这带来了临床挑战.
- 逐渐减少tizanidine的剂量可以加速戒断症状.
研究的目的:
- 在患有慢性疼痛的患者中报告复杂的tizanidine戒断病例.
- 描述一个独特的tizanidine戒断症状的管理策略.
- 强调在药物降级期间个性化患者护理的重要性.
主要方法:
- 一名68岁的女性患者患有慢性疼痛,在降低蒂扎尼丁剂量时出现了戒断症状.
- 戒断症状包括高血压,低心率和严重的身体疼痛.
- 用于管理戒断综合征,给予了一次性费诺巴比塔尔剂量.
主要成果:
- 法诺巴比塔尔的使用成功地解决了患者的血液动力学不稳定性和疼痛.
- 提扎尼丁的治疗完全停止,没有进一步的并发症.
- 患者因持续的疼痛管理而转换为 methocarbamol,反应良好.
结论:
- 提扎尼丁的戒断可能会出现显著的心血管和疼痛症状.
- 一次剂量的芬诺巴比塔尔可能是有效的,尽管非常规的,治疗提桑尼丁戒断.
- 个性化治疗策略对于治疗慢性疼痛患者复杂药物戒断至关重要.
相关概念视频
Antiepileptic Drugs: Potassium Channel Activators
183
Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
Ezogabine has gained approval as an adjunctive treatment...
183
Desensitization and Tachyphylaxis
1.7K
Tachyphylaxis is described as a rapid decrease in response to a drug after repeated or continuous administration of the same drug dose. It is a phenomenon where the body becomes less responsive to a particular substance or intervention over time, requiring higher doses or stronger interventions to achieve the same effect. It results from adaptive changes in the body's receptors, signaling pathways, or physiological processes that occur in response to prolonged exposure to a stimulus.
1.7K
CNS Depressants: Barbiturates and Benzodiazepines
263
CNS depressants include drugs from the category of barbiturates and benzodiazepines. They are valuable medications for managing anxiety disorders and insomnia. Barbiturates, once used to induce and maintain sleep, have been replaced mainly by benzodiazepines due to barbiturate's toxicity, tolerance, and overdose risks. They interact with GABAA receptors, leading to sedation at low doses and potentially coma and death at higher doses. Phenobarbital, a long-acting barbiturate, possesses...
263
Drug Dependence
1.0K
Medications are typically administered to achieve therapeutic effects. Some drugs can modify an individual's mood and perception, frequently resulting in various enjoyable experiences. However, this can result in drug dependency, a condition marked by continuous drug use despite potential negative consequences. Drug dependency primarily falls into two categories: psychological and physical dependence. Psychological dependence occurs when the pleasurable feelings induced by the drug...
1.0K
Sedatives and Hypnotics Drugs: Miscellaneous Agents
172
Sedatives and hypnotics encompass a wide range of substances, each with its unique mechanism of action, uses, and potential adverse effects.
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
172
Anxiolytic Drugs: Benzodiazepines and Buspirone
742
Benzodiazepines are a class of anxiolytic drugs known for their rapid efficacy and high therapeutic-to-lethal dose ratio, but with a potential risk of drug dependence. These drugs are lipophilic, allowing for rapid absorption after oral administration, eventually reaching the central nervous system (CNS). Once in the CNS, benzodiazepines bind to the allosteric site of the GABAA receptor. This binding enhances the inhibitory effects of the neurotransmitter GABA. By doing so, they prevent...
742


